Home » Topics » Regulatory » Patents

Patents
RSS

Anti-HIV vaccines reported by Duke University

June 6, 1997

New influenza vaccine prepared by Yissum

June 6, 1997

Agents for HIV, tumors and autoimmune diseases from Boehringer Mannheim

June 6, 1997

Fibrinogen antagonists from Merck & Co.

June 6, 1997

Preparation and use of 5alpha-reductase type 1 inhibitors described by Merck & Co.

June 6, 1997

Takeda describes GnRH antagonists

June 6, 1997

Fujisawa discloses agents for bone metabolism disorders

June 6, 1997

NEP/ACE/ECE inhibitors described by Wakamoto

June 4, 1997

U. of California discloses mammalian EPO-BP

June 4, 1997

Anti E- and P-selectin antibodies from PDL

June 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...